The Annexure

News to 9 October 2026 ·

Desk›Chemicals› Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Ltd

BSE 524768 · NSE EMMESSA · ISIN INE634B01016 · Group X · Active

Commodities › Chemicals › Chemicals & Petrochemicals › Commodity Chemicals

₹24.38

+2.87%

BSE close, 28 August 2026

Market cap

₹12.18 cr

0.5 cr shares · Micro cap

Free float

₹4.93 cr

as published

P/E · P/B

28.0× · 1.57×

EPS ₹0.87 · BV ₹15.53

FY25-26 rev / PAT

0.37 / 0.44

₹ cr, as filed

Filings, window

12

2 selected · 17%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹18.42 52-WK HIGH ₹42.75 ₹24.38 24% of range
Against 52-week high-43.0%
Against 52-week low+32.4%
Day change+2.87%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹0.87
Price / earnings28.02×
Price / book1.57×
Book value — derived, price ÷ P/B₹15.53
Return on equity5.60%
Operating margin113.98%
Net margin36.56%

Consistency check

P/B ÷ P/E, which must equal ROE
5.60%
ROE as published
5.60%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Mar-26 · Q 0.09 0.03 0.01 113.98% 36.56%
Dec-25 · Q 0.09 0.12 0.23 166.67% 124.73%
FY25-26 0.37 0.44 0.81 184.10% 117.52%

Quarter on quarter

Revenue, quarter on quarter
+0.0%
Net profit, quarter on quarter
-75.0%
Operating margin, quarter on quarter
-5,269 bps

Disclosure profile 12 filings in the window

0 median 16.0 sector max 62 12 33th percentile of 300 Chemicals filers
Shaded is the middle half of the sector, 12 to 20 filings. Measured against the 300 Chemicals companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Results1
Selected sub-total2
Procedural
General4
AGM / EGM3
Annual Report1
Compliance Certificate1
Trading Window1
Procedural sub-total10
Total12

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

12 filings · 2 selected · busiest 2026-09-04

Filing rhythm · the twelve most recent

2026-08-072026-10-09

SelectedProcedural

Filings

12 in the window · 2 earlier on record

  1. 9 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please refer attachment

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 2 October 2026 ·

    General

    Newapaper Add For Relodgment Of Shares

    Please refer attachment

    Company Update / General View filing →

  3. 29 September 2026 ·

    Trading Window

    Closure of Trading Window

    Please refer attachment

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 29 September 2026 ·

    AGM / EGM

    Scutinizers Report

    Please refer attachement

    AGM/EGM / AGM View filing →

  5. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Please refer attachment

    AGM/EGM / AGM View filing →

  6. 4 September 2026 ·

    General

    Communication To Shareholders Whose Email Ids Are Not Registered

    Please refer attachment

    Company Update / General View filing →

  7. 4 September 2026 ·

    General

    Communication Sent To Shareholders Holding Physical Shares

    Please refer attachment

    Company Update / General View filing →

  8. 4 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Please refer attachment

    Others / Reg. 34 (1) Annual Report View filing →

  9. 4 September 2026 ·

    AGM / EGM

    Notice Of The 34Th Annnual General Meeting Of The Company To Be Held On September 29, 2026

    Please refer attachment

    AGM/EGM / AGM View filing →

  10. 27 August 2026 ·

    General

    Newspaper Add For AGM

    Please refer attachment

    Company Update / General View filing →

  11. 7 August 2026 ·

    Results

    Unaudited Financial Results For The Quarter Ended June 30, 2026

    Please refer attachement

    Result / Financial Results View filing →

  12. 7 August 2026 ·

    Board Outcome

    Board Meeting Outcome for For Unaudited Financial Results For The Quarter Ending June 30, 2026

    Please refer attachement

    Board Meeting / Outcome of Board Meeting View filing →

RSS feed for Emmessar Biotech & Nutrition Ltd · the 50 most recent filings